Loreen Straub

Brigham and Women’s Hospital and Harvard Medical School, United States

Disclosure information not submitted.

Presentation(s):

• 1E-01 - Dose-Dependent Risk of Psychosis in Patients with Attention-Deficit/Hyperactivity Disorder Treated with Prescription Amphetamine

  Sunday, August 24, 2025
  10:30 AM - 10:45 AM ET

• 1F-06 - Optimization of ICD-10-based algorithms for estimating gestational age for live and non-live births in healthcare databases

  Sunday, August 24, 2025
  11:45 AM - 12:00 PM ET

• 2F-04 - Tree-based Scan Statistics to Evaluate Drug Safety in Pediatric Populations: Sulfamethoxazole/trimethoprim as a Positive Test Case

  Sunday, August 24, 2025
  4:15 PM - 4:30 PM ET

• 2G-06 - Benzodiazepines and spontaneous abortions: sequential target trial emulation design and other methodological considerations

  Sunday, August 24, 2025
  4:45 PM - 5:00 PM ET

• 3G-01 - GLP-1 receptor agonist continuation into the first trimester of pregnancy and risk of non-live birth and abnormal fetal growth: a target trial emulation

  Monday, August 25, 2025
  8:15 AM - 8:30 AM ET

• 4F-02 - Screening for Pediatric Safety Alerts Following Antipsychotic Treatment Initiation using a Tree-Based Scan Statistics Approach

  Monday, August 25, 2025
  4:30 PM - 4:45 PM ET

• 4F-04 - Clinically Recognized Congenital Cytomegalovirus Infection and the Risk of Neurodevelopmental Disorders

  Monday, August 25, 2025
  5:00 PM - 5:15 PM ET